Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03592641
Title Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Savolitinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST